Hi, what are you looking for?
BOJ to keep rates steady as politics muddles outlook
Facebook parent Meta projects sharp acceleration in AI costs after results beat Wall Street targets
‘Trump trade’ could reverse on signs Trump would lean hawkish on fiscal policy
Does Trump really want to compare now to four years ago?
Canada would have to double defense spending by 2032-33 to meet NATO target, watchdog says
Earnings call: O-I Glass Q3 2024 results show adjusted net loss
Earnings call: Check Point Software reports solid Q3 with strategic growth
Earnings call: ILPT maintains dividend amid mixed Q3 financials
Earnings call: Civista Bancshares reports mixed Q3 results amid transitions
Earnings call: Kiniksa Pharma’s Q3 2024 shows strong ARCALYST sales growth
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
Early voting in Wisconsin slowed by label printing problems
American creating deepfakes targeting Harris works with Russian intel, documents show
Nvidia overtakes Apple as world’s most valuable company
JPMorgan begins suing customers who allegedly stole thousands of dollars in ‘infinite money glitch’
Immersive entertainment company Cosm lands rights to broadcast NFL games
Delta sues CrowdStrike after widespread IT outage that caused thousands of cancellations
Boeing machinists reject new labor contract, extending strike
In the recent O-I Glass, Inc. (NYSE: NYSE:OI) Third Quarter 2024 Earnings Conference Call, CEO Gordon Hardie discussed the company’s financial results, revealing an...
Civista Bancshares Inc. (NASDAQ: NASDAQ:CIVB) reported an 18% increase in net income to $8.4 million, or $0.53 per diluted share, for the third quarter...
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: NASDAQ:KNSA) reported a notable increase in ARCALYST net product revenue, achieving $112.2 million in the third quarter of 2024, a...
“And there’s very few states that benefit like you do from fracking. I mean, you have 500,000 jobs.” — Former president Donald Trump, remarks...
DULUTH, Ga. — Former Fox News host Tucker Carlson warmed up the crowd at Donald Trump’s rally here Wednesday night with a dark metaphor,...
Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...
MADISON, Wis. — Early voting kicked off in this battleground state this week with computer delays and long lines. Voters waited as long as...
By Leika Kihara TOKYO (Reuters) – The Bank of Japan is expected to maintain ultra-low interest rates on Thursday and signal a cautious approach...
By Katie Paul, Akash Sriram (Reuters) -Facebook owner Meta Platforms (NASDAQ:META) beat analysts’ estimates for third-quarter revenue and profit on Wednesday, but warned of...
Investing.com — Reports that a second potential Donald Trump presidency could include fiscal hawks in his administration focused on aggressively cutting fiscal spending, threatens...
By Howard Schneider WASHINGTON (Reuters) – Republican presidential candidate and former President Donald Trump’s end-of-campaign arguments to voters choosing between him and Democrat Kamala...
Check Point Software Technologies Ltd. (NASDAQ:CHKP) reported a strong third quarter in 2024, with CEO Gil Shwed and CFO Roei Golan presenting a positive...
(Reuters) -Hyundai Motor India’s $3.3 billion IPO opened for bids on Tuesday, aiming for a valuation of up to $19 billion in India’s largest...
BERLIN – Eckert & Ziegler SE, a TecDAX-listed company, has reported an increase in sales for the first nine months of 2024, achieving EUR...
By Lisa Pauline Mattackal and Purvi Agarwal (Reuters) – The S&P 500 and the Nasdaq edged higher while the Dow dropped on Tuesday, with...
WASHINGTON (Reuters) – The U.S. Transportation Department said Tuesday it is imposing a $4 million penalty against Lufthansa for discriminating against Jewish passengers from...
(Reuters) – GlaxoSmithKline (NYSE:GSK) sued Moderna (NASDAQ:MRNA) in Delaware federal court on Tuesday for allegedly violating GSK’s patent rights in messenger RNA (mRNA) technology...
